TipRanks
AstraZeneca Pharma India Limited (IN:ASTRAZEN)
:ASTRAZEN
India Market
ASTRAZEN
AstraZeneca Pharma India Limited
RESEARCH TOOLSreports
Want to see IN:ASTRAZEN full AI Analyst Report?

AstraZeneca Pharma India Limited (ASTRAZEN) Stock News & Sentiment

42 Followers
AstraZeneca Pharma India Confirms SEBI Dematerialization Compliance for Q2 FY2026
Premium
Company Announcements
AstraZeneca Pharma India Confirms SEBI Dematerialization Compliance for Q2 FY2026
5d ago
Delhi High Court Grants AstraZeneca India Interim Relief in NPPA Drug Pricing Dispute
Premium
Company Announcements
Delhi High Court Grants AstraZeneca India Interim Relief in NPPA Drug Pricing Dispute
2M ago
AstraZeneca Pharma India Discloses Unsolicited ESG Rating from Crisil
Premium
Company Announcements
AstraZeneca Pharma India Discloses Unsolicited ESG Rating from Crisil
2M ago
AstraZeneca Pharma India Plans Virtual Meeting With Institutional Investor
Premium
Company Announcements
AstraZeneca Pharma India Plans Virtual Meeting With Institutional Investor
2M ago
AstraZeneca Pharma India Schedules Virtual Meet with Institutional Investor
Premium
Company Announcements
AstraZeneca Pharma India Schedules Virtual Meet with Institutional Investor
3M ago
AstraZeneca Pharma India Clears Dividend and Board Moves at 47th AGM
Premium
Company Announcements
AstraZeneca Pharma India Clears Dividend and Board Moves at 47th AGM
3M ago
AstraZeneca Pharma India posts 30% revenue surge in Q1 FY2026–27 driven by core therapies
Premium
Company Announcements
AstraZeneca Pharma India posts 30% revenue surge in Q1 FY2026–27 driven by core therapies
3M ago
More IN:ASTRAZEN News >

ASTRAZEN News on the Web

Delhi High Court Grants AstraZeneca India Interim Relief in NPPA Drug Pricing Dispute
TipRanks News
Neutral
AstraZeneca Pharma India Schedules Virtual Meet with Institutional Investor
TipRanks News
Neutral
AstraZeneca Pharma India Wins New Breast Cancer Approval for Enhertu
TipRanks News
Bullish
AstraZeneca Pharma India Confirms SEBI-Compliant Dematerialization for Q1 FY27
TipRanks News
Neutral
AstraZeneca Pharma India Surrenders Factory License as It Exits Manufacturing Site
TipRanks News
Neutral
AstraZeneca Pharma India Wins New Approval for Calquence Use in Untreated CLL and SLL
TipRanks News
Neutral

News Score - Last 7 Days

Neutral
IN:ASTRAZEN
Sector Average
Media Buzz
This Week1 articles
Weekly Average0 articles
News Sentiment
This Week100%
Sector Average89%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is IN:ASTRAZEN’s Media Buzz Sentiment?
Currently, no data Available
What is IN:ASTRAZEN’s weekly average amount of articles?
Currently, no data Available
What is IN:ASTRAZEN’s News Sentiment?
100% of articles about IN:ASTRAZEN were positive this week, compared to its sector average of 89%.
    General Stocks that are Trending in the News
    RPDRapid7
    TERATera Yatirim Menkul Degerler AS
    R2PD34Rapid7 Inc Shs Unsponsored Brazilian Depositary Receipt Repr 0.083333 Sh
    T2TD34Trade Desk, Inc. Shs A Unsponsored Brazilian Depositary Receipt Repr 0.01 Sh A
    T1AM34Atlassian Corp Shs A Unsponsored Brazilian Depository Receipt Repr 0.05 Sh A
    Showing the stocks with the most bullish news sentiment over the past week